期刊文献+

Fluorochrome-labeled monoclonal antibody with characteristic M-shaped spectral peak for optical imaging: Dual-labeling versus mixture of fluorochromes

Fluorochrome-labeled monoclonal antibody with characteristic M-shaped spectral peak for optical imaging: Dual-labeling versus mixture of fluorochromes
原文传递
导出
摘要 In this work two different fluorochromes (Alexa 594 and Alexa 680) are conjugated to the same monoclonal antibody (Cetuximab) for obtaining a characteristic M-shaped dual-peak spectrum. Dual-labeling of Cetuximab by mixing both fluorochromes before the conjugation step gives spectral results similar to those of mixing of fluorochrome-labeled Cetuximab after the conjugation step (P 〉 0.05). In conclusion, both methods may be used equivalently for producing a dual-labeled single-antibody probe. Future studies may test whether the M-shaped spectrum may increase the diagnostic confidence in tumor-targeted multispectral optical imaging. In this work two different fluorochromes (Alexa 594 and Alexa 680) are conjugated to the same monoclonal antibody (Cetuximab) for obtaining a characteristic M-shaped dual-peak spectrum. Dual-labeling of Cetuximab by mixing both fluorochromes before the conjugation step gives spectral results similar to those of mixing of fluorochrome-labeled Cetuximab after the conjugation step (P 〉 0.05). In conclusion, both methods may be used equivalently for producing a dual-labeled single-antibody probe. Future studies may test whether the M-shaped spectrum may increase the diagnostic confidence in tumor-targeted multispectral optical imaging.
出处 《Chinese Optics Letters》 SCIE EI CAS CSCD 2015年第5期74-78,共5页 中国光学快报(英文版)
  • 相关文献

参考文献33

  • 1A. Taruttis and V. Ntziachristos, Am. J. Roentgenol. 199, 263 (2012).
  • 2L. Xiong, E. Gazyakan, W. Yang, H. Engel, M. Hiinerbein, U. Kneser, and C. Hirche, Eur. J. Surg. Oncol. 40, 843 (2014).
  • 3D. R. Left, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, Breast. Cancer Res. Treat. 108, 9 (2008).
  • 4G. Wang, H. Zhao, Q. Ren, and C. Li, Chin. Opt. Lett. 12, 051703 (2014).
  • 5X. Li, J. Yang, X. Sheng, J. Zhang, D. Cui, Q. Peng, and Z. Xu, Chin. Opt. Lett. 11, 111901 (2013).
  • 6W. Xie, Y. Liu, Z. Li, and H. Li, Chin. Opt. Lett. 12, 051702 (2014).
  • 7S. Oliveira, R. Cohen, M. S. Walsum, G. A. van Dongen, S. G. Elias, P. J. van Diest, W. Mall, and P. M. van Bergen En Henegouwen, EJNMMI Res. 2, 50 (2012).
  • 8S. Ke, X. Wen, M. Gurfinkel, C. Charnsangavej, S. Wallace, E. M. Sevick-Muraca, and C. Li, Cancer Res. 63, 7870 (2003).
  • 9I. Zafir-Lavie, Y. Michaeli, and Y. Reiter, Oncogene 26, 3714 (2007).
  • 10D. M. Goldenberg and R. M. Sharkey, Oncogene 26, 3734 (2007).

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部